Alnylam Pharmaceuticals
ALNY
#696
Rank
C$51.17 B
Marketcap
C$383.29
Share price
1.13%
Change (1 day)
-13.87%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company